US biotech Gilead Sciences has now been awarded damages totalling nearly a quarter of a billion dollars in a case that the drugmaker filed against several healt 10 March 2023
A judge in the USA has dismissed litigation against Bristol Myers Squibb, alleging the New York-based company defrauded former Celgene shareholders out of $6.4 3 March 2023
Pharma companies participating in the 340B drug pricing program in the USA do not have to provide medicines ad nauseam to contract pharmacies. 31 January 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.